ADAR1 Capital Management »

Cantor Equity Partners Vi In shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Cantor Equity Partners Vi In (CEPS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Cantor Equity Partners Vi In

Tip: Access up to 7 years of quarterly data

All positions including Cantor Equity Partners Vi In held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cantor Equity Partners Vi In by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $202k 20k 10.10

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Cantor Equity Partners Vi In

OZ Management
Toronto-Dominion Bank
LMR Partners
Polar Securities
Context Capital Management
Empyrean Capital Partners
Mozayyx Management
Saba Capital Management
Sona Asset Management
Jain Global
Harraden Circle Investments
Moore Capital Management
Tenor Capital Management
HBK Investments
Hudson Bay Capital Management

View all funds holding Cantor Equity Partners Vi In